Biologics Market: Is 2026 the Year "mRNA Beyond COVID" Becomes the New Foundation for Chronic Disease
In 2026, the Biologics Market is proving that the mRNA revolution was only the beginning. While the world focused on vaccines in years past, 2026 has seen the launch of the first "mRNA Therapeutics" designed to treat genetic heart conditions and rare metabolic disorders. This "Programmable Medicine" trend is a key driver of the 2026 market, as it allows researchers to "Instructionalize" a...
0 Kommentare 0 Geteilt 70 Ansichten 0 Bewertungen
Gesponsert